Patient selection for radical surgery for mesothelioma—prognostic factors in a multimodality approach

Abstract

In the absence of standardized treatment algorithms for malignant pleural mesothelioma patients, one of the main difficulties remains patient allocation to therapies with potential benefit. In the following article, we discuss clinical, pathological and molecular prognostic factors, which have been investigated over the past years to simplify and at the same time specify patient selection for multimodality treatment.